International Prognostic Score in Advanced-Stage Hodgkins Lymphoma: Altered Utility in the Modern Era
Journal of Clinical Oncology, 08/08/2012
Moccia AA et al. – The International Prognostic Score (IPS) remains prognostic for advanced–stage Hodgkin’s lymphoma (HL), but the range of outcomes has narrowed considerably. This improvement in outcome with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) should be acknowledged before consideration of alternate initial therapies and when comparing results from current trials with those of historic controls.